MedTrace Logo

The Volumizing Effect of Juvéderm VOLUMA® in the Mid-Face

NCT01559064 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2014-10-13

Study results available
· View outcomes & findings →

Summary

This is a prospective, observational study of the volumizing effect of aesthetic use of Juvéderm VOLUMA® with lidocaine in the mid-face area.

Conditions

  • Age-related Volume Deficit in the Mid-face

Interventions

DEVICE

Crosslinked hyaluronic acid gel (Juvéderm VOLUMA®)

All treatment details are at the discretion of the investigator and should be guided by the appropriate directions for use.

Sponsors & Collaborators

  • Allergan Medical

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Allergan Medical

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Belgium
  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01559064 on ClinicalTrials.gov